We demonstrated that PARP-1 inhibitors, PHEN and PJ34, markedly enhanced APR-246-induced cell death in HNSCC cells (Figure 1 and Supplementary Figure 1). The gene discussed is PARP1; the disease is head and neck squamous cell carcinoma.